Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Emergent BioSolutions Inc.

NYSE: EBS · Life Sciences · 7 alerts · CIK 1367644

Share price
$5.81Close, Nov 16
Market cap
$299M
Shares outstanding
51.42MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Emergent BioSolutions Inc. filings on SEC EDGAR ↗

4:03 PM ET 8-K
Investor Presentation

Emergent BioSolutions Investor Presentation

Emergent BioSolutions CEO Joseph C. Papa is presenting at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026. The company filed a formal investor presentation deck as an exhibit, which outlines its strategy for combating public health threats and provides updates on its medical countermeasure portfolio, including CYFENDUS and NARCAN.

Counterparty
H.C. Wainwright

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.